CINACALCET TEVA 90 mg, film-coated tablet 28 tablets, CIP 3400930047354
Active ingredients: Cinacalcet hydrochloride, Cinacalcet
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Film-coated tablet28 tablets, CIP 3400930047354orale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- CINACALCET TEVA 90 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène PVC-Aluminium de 28 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 24 Mar 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64656654CIP73004735CIP133400930047354Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CINACALCETcomprimé | 90 mg · un comprimé | FT |
| CHLORHYDRATE DE CINACALCETcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.